Concepedia

Kevin M. Byrne

KM

22

Publications

827

Citations

20

H-Index

1974

Active since

Affiliations

MSD (Spain)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Cancer Research Center

Rutgers, The State University of New Jersey

Kevin M. Byrne is an author at MSD (Spain) specializing in microbiology, medicine, and pharmacology.

Top concepts

Publications per year

1974–2009

22

Publications

22

Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.

Ramesh C. Pandey, Margaret W. Toussaint, Ronald M. Stroshane et al. · The Journal of Antibiotics · 1981 · 109 citations

Biosynthesis of Nodulisporic Acid A:  Precursor Studies

Kevin M. Byrne, Scott K. Smith, John G. Ondeyka · Journal of the American Chemical Society · 2002 · 65 citations

Fredericamycin A a new antitumor antibiotic. II. Biological properties.

DANA J. WARNICK-PICKLE, Kevin M. Byrne, Ramesh C. Pandey et al. · The Journal of Antibiotics · 1981 · 61 citations · Full text

Studies on the mechanism of action of gilvocarcin V and chrysomycin A.

Tena Wei, Kevin M. Byrne, DANA WARNICK-PICKLE et al. · The Journal of Antibiotics · 1982 · 55 citations · Full text

, , +11

Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation

Jennifer Nielsen, Ming Jo Hsu, Kevin M. Byrne et al. · Biochemistry · 1991 · 43 citations

Rows per page

1–5 of 22